EUVIMEDEUVIMED entdecken
Open Access

Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques

So-Yon Lim iD, Jina Lee iD, Christa E Osuna iD, Pratik Vikhe iD, Dane R Schalk iD, Elsa Chen, Emily Fray iD, Mithra Kumar iD, Nancy Schultz-Darken iD, Eva Rakasz iD, Saverio Capuano, Ruby A Ladd iD und 15 weitere

Science · 08.03.2024 · 383 (6687) · 1104-1111

DOI: 10.1126/science.adf7966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 08.03.2024. Verfasst von So-Yon Lim und 26 weiteren Autor:innen. Beteiligte Einrichtung: Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. Hauptthemen laut MEDLINE: Anti-Retroviral Agents, Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus, Recombinant Fusion Proteins. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The eradication of the viral reservoir represents the major obstacle to the development of a clinical cure for established HIV-1 infection. Here, we demonstrate that the administration of N-803 (brand name Anktiva) and broadly neutralizing antibodies (bNAbs) results in sustained viral control after discontinuation of antiretroviral therapy (ART) in simian-human AD8 (SHIV-AD8)–infected, ART-suppressed rhesus macaques. N-803+bNAbs treatment induced immune activation and transient viremia but only limited reductions in the SHIV reservoir. Upon ART discontinuation, viral rebound occurred in all animals, which was followed by durable control in approximately 70% of all N-803+bNAb–treated macaques. Viral control was correlated with the reprogramming of CD8 + T cells by N-803+bNAb synergy. Thus, complete eradication of the replication-competent viral reservoir is likely not a prerequisite for the induction of sustained remission after discontinuation of ART.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Retroviral AgentsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusRecombinant Fusion ProteinsAnimalsHumansBroadly Neutralizing AntibodiesCD8-Positive T-LymphocytesImmunotherapyMacaca mulattaViral LoadRemission InductionDrug Therapy, Combination

Substanzen

Anti-Retroviral AgentsBroadly Neutralizing AntibodiesALT-803Recombinant Fusion Proteins

Autor:innen und Institutionen

  • Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
  • Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI 53715, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
  • Altor Biosciences, Miramar, FL 33027, USA.
  • Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
  • Los Alamos National Laboratory, Los Alamos, NM 87545, USA.

ORCID-Profile: So-Yon Lim, Jina Lee, Christa E Osuna, Pratik Vikhe, Dane R Schalk, Emily Fray, Mithra Kumar, Nancy Schultz-Darken, Eva Rakasz, Ruby A Ladd, Hwi Min Gil, David T Evans, Michael Seaman, Malcolm Martin, Christiaan Van Dorp, Alan S Perelson, Janet D Siliciano, Robert Siliciano, Douglas F Nixon, Patrick Soon-Shiong, Michel Nussenzweig, James B Whitney

Förderung

  • NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Lim, S. Y., Lee, J., Osuna, C. E., Vikhe, P., Schalk, D. R., Chen, E., Fray, E., Kumar, M., Schultz-Darken, N., Rakasz, E., Capuano, S., Ladd, R. A., Gil, H. M., Evans, D. T., Jeng, E. K., Seaman, M., Martin, M., Van Dorp, C., Perelson, A. S., …, & Whitney, J. B. (2024). Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science, 383(6687), 1104-1111. https://doi.org/10.1126/science.adf7966

Vancouver

Lim SY, Lee J, Osuna CE, Vikhe P, Schalk DR, Chen E, et al. Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques. Science. 2024;383(6687):1104-1111. doi:10.1126/science.adf7966

BibTeX
@article{Lim2024,
  author = {Lim, So-Yon and Lee, Jina and Osuna, Christa E and Vikhe, Pratik and Schalk, Dane R and Chen, Elsa and Fray, Emily and Kumar, Mithra and Schultz-Darken, Nancy and Rakasz, Eva and Capuano, Saverio and Ladd, Ruby A and Gil, Hwi Min and Evans, David T and Jeng, Emily K and Seaman, Michael and Martin, Malcolm and Van Dorp, Christiaan and Perelson, Alan S and Wong, Hing C and Siliciano, Janet D and Siliciano, Robert and Safrit, Jeffrey T and Nixon, Douglas F and Soon-Shiong, Patrick and Nussenzweig, Michel and Whitney, James B},
  title = {Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques},
  journal = {Science},
  year = {2024},
  volume = {383},
  number = {6687},
  pages = {1104--1111},
  doi = {10.1126/science.adf7966}
}
Kostenlos starten →